New award for orphenadrine tablets with sandoz INC. Period of performance is 12/14/2020 to 12/13/2021 with four one-year options.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36E79720D0048
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$164,608.40
Award type
Single award
Who can order
All agencies
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The federal government has awarded an Indefinite Delivery Contract to Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars, to supply a variety of prescription medications through the VA and DoD pharmaceutical prime vendor programs. The contract, valued up to $164,608.40, has a base year plus four one-year option periods, and aims to meet the medication needs of veterans, active duty military personnel, federal inmates, and Native American populations served by the healthcare networks.

Specifically, the contract covers the supply of Orphenadrine Citrate 100mg Sustained Action Tablets, with an estimated annual requirement of 1,672 bottles. The contract was awarded by the National Acquisition Center, a civilian federal agency, with no set-asides, and the products will be distributed through the VA's prime vendor program to VA medical centers, DoD, Bureau of Prisons, and Indian Health Services facilities. The contract was originally solicited through a pre-solicitation notice, which provided details on the scope, NAICS code, and point of contact for interested offerors.

Transactions

Action Obligated Date
Add Subcontract Plan P00012 · Incorporate sandoz's 2025 subk plan into contract. Plan effective 1/2/2025 - 12/31/2025. $0
Exercise an Option P00011 · Exercise the fourth and final option year for orphenadrine tablets contract 36E79720D0048 with sandoz, INC. With no price changes. $0
Supplemental Agreement for work within scope P00009 · Update to cost recovery fee (CRF) and submission of quarterly sales reports 36E79720D0048, sandoz, INC. For orphenadrine SA tablets. $0
Other Administrative Action P00010 · Change sandoz, INC. POC from evelyn bergman to eric shinn. $0
Add Subcontract Plan P00008 · Incorporate sandoz, INC. 2024 subk plan into contract. $0
Exercise an Option P00007 · Exercise the third option year for orphenadrine contract 36E79720D0048 with sandoz, INC. With no price changes. $0
Other Administrative Action P00006 · Incorporate updated dscsa language and requirements into VA national contract 36E79720D0048. $0
Add Subcontract Plan P00005 · Incorporate 2023 subcontracting plan $0
Exercise an Option P00004 · Exercise the second option year for orphenadrine contract 36E79720D0048 with sandoz, INC. With no price changes. $0
Add Subcontract Plan P00003 · Incorporation of 2022 small business subcontracting plan, effective 1/1/2022 - 12/31/2022. $0
Exercise an Option P00002 · Exercise the first option year for orphenadrine tablets with sandoz, INC. With no price changes. Period of performance is 12/14/2021 - 12/13/2022 $0
Add Subcontract Plan P00001 · Incorporation of 2021 small business subcontracting plan, effective 1/1/2021 - 12/31/2021. $0
Original award $0
Show all 13

Quick answers

Who was awarded contract 36E79720D0048?

36E79720D0048 was awarded to Sandoz Inc. by National Acquisition Center (Headquarters) on December 14, 2020.

How much is contract 36E79720D0048 worth?

36E79720D0048's own ceiling is $164,608.

Who can order from contract 36E79720D0048?

36E79720D0048 is a single award indefinite delivery contract. All agencies can place orders on it.

Was contract 36E79720D0048 competed?

The extent of competition for 36E79720D0048 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV